Moderna Looking To Price Its Coronavirus Vaccine At $50-$60, Significantly Above Rivals: FTBenzinga • 07/29/20
Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)Business Wire • 07/28/20
Scripta Insights Co-founder & Chief Medical Officer Paul S. Bradley, MD, at Forefront of Medical Advancement, Doses First Patient in Moderna's U.S.PRNewsWire • 07/27/20
Dr. Anthony Fauci isn't 'particularly concerned' about safety of Moderna coronavirus vaccineCNBC • 07/27/20
Cramer: Moderna sets 'pace of overoptimism' on how quickly a coronavirus vaccine could be readyCNBC • 07/27/20
Moderna Shares Rebound As Biopharma Starts Late-Stage Coronavirus Vaccine Trial, Snags More FundingBenzinga • 07/27/20
Moderna’s 30,000-participant Phase 3 COVID-19 vaccine trial kicks off in the U.S.TechCrunch • 07/27/20
Moderna Starts Phase 3 Trial For Its Coronavirus Vaccine; MRNA Stock JumpsInvestors Business Daily • 07/27/20
Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) BeginsBusiness Wire • 07/27/20
Moderna's stock surges as new funding sets Phase 3 trial of COVID-19 vaccine candidate to start 'immediately'Market Watch • 07/27/20
Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine DevelopmentBenzinga • 07/27/20